During a debate session on embryo testing and the fourteen-day rule, an argument was raised in favour of scrapping all testing on human embryos; the claim was that, in the early stages of embryo development, vertebrates have “deep structural similarities“, so animal embryos can be used in place of human ones for all relevant research.
The claim that animal and human embryos are indistinguishable enough that animals can be considered ‘good enough’ for human research is a debatable one, but this was not what stuck with me after the debate session. I found myself unsettled by the ease with which “let’s just use animals” became a conclusion from those who supposedly value life enough to argue against embryo testing in its entirety. It seemed contradictory to me; a pro-life stance displayed unexpected double standards concerning the morals surrounding humans and other vertebrates.
Though my current degree is in biomedical engineering, my future goal is to pursue a career in veterinary medicine. I have had pets from a young age and believe the companionship and trust of an animal to be one of the greatest experiences available to us in our lifetime. Part of my decision to take this module is my long-term interest in the work of Noel Fitzpatrick on developing prosthetic limbs for animals, hence saving the lives of pets who would otherwise be put down, or not afforded the same care that a human patient would be. I value life regardless of species, and as a consequence, lean towards standing against animal testing.
Animal testing for medical research is an extensive field, ranging from the aforementioned embryo research to tests on conscious animals, where many are subject to deliberate harm. I am struggling to type this section of the post and am procrastinating on my research into the details of animal testing. I cannot bring myself to insert images I’ve seen from secret surveillance of testing at Wickham Laboratories. My impulse reaction is to condemn it for its cruelty. For the most part, a human has a choice. An animal does not.
Naturally, the ethical debate is heated. Many organisations oppose all animal testing and strive to eradicate it; their websites are full of stock images of animals in cages that make me want to shut my laptop and perhaps switch to a humanities degree. It is also a highly profitable industry, which, in the realm of medicine, is a statement that should always sound alarm bells. Some claim animals should be afforded the same rights as humans, as “individuals with inherent value“.
Whilst I am no vegan, I am inclined to agree in the context of the suffering undergone in many animal testing regimes. Even my word choice here should be considered; the distinction between ‘human’ and ‘animal’ is being made when it could be argued that we are one in the same. I am using these words for ease of communication, but whilst I write, am considering whether I truly believe this separation to be just.
Of course, the benefits are numerous and significant. Eradication of certain diseases, such as smallpox and polio, has been achieved through animal testing. As a notable example, eradication of AIDS is on the horizon. Animal research has developed our understanding of transplantation, anatomy, biological systems, behaviour, pain, and memory, to name but a few. Some benefits cannot be replicated in human alternatives, such as the availability of a shorter lifespan, where the effects of procedures or drugs on an organism can be observed over a whole life cycle and experimental times can be shortened.
The role of non-human animals to serve our betterment as a species is a viewpoint that can be found as far back as the Bible. Christian theologians support a hierarchy of animals, and it is not difficult to see how this idea, in the cultural Christianity of the Western world, remains an influence on the ethics of animal research.
(Once again, I view this as a stance contradictory to another argument that Christianty backs up using faith: that abortion is immoral, since life begins at conception. How does one religion support the rights of a handful of cells to such an extreme, whilst condemning non-human animals as simply tools of humanity? But that is an issue to tackle another day.)
I have spent many a weekend in the library over the course of my degree. This one is by far the most intense. I cannot hope to organise my thoughts on the whole topic of animal testing in one sitting, with nothing but my Thermos flask of tea as emotional support. Hence, I will consider a scenario where the issue of animal testing has directly affected me.
Crimean-Congo Haemorrhagic Fever
Since February 2024, I have been involved in the first phase of human clinical trials for a vaccine against the virus causing Crimean-Congo haemorrhagic fever (CCHF). It is endemic in regions the primary tick vector is native to, but has spread further due to animal-to-human and human-to-human transmission. Outbreak fatality rates vary depending on the source, but the NHS suggests a fatality rate of up to 80%. Readers may aready be aware of the CCHF virus; in 2023, concerns rose about its imminent spread across Europe, and its trajectory towards the UK.
It is clear that this virus is a pressing concern. Phase one of the human trials for the MVA-based vaccination were recently begun by the National Institute for Health and Care Research; I joined the study as a healthy volunteer at the Southampton Clinical Research Facility, receiving two doses of the vaccine with monitoring of my immune response throughout. My final session was completed on Tuesday 18th March 2025.
Animal testing often precedes the human phases of a drug trial. According to the RSPCA, who advocate for human alternatives wherever possible, around 5 million animals are used annually across the EU alone for research into medicine and vaccinations. This is a hot topic; in 2023, the US government ruled that the FDA no longer required animal testing for new drugs to be approved. A recent study claims that only 5% of animal tested drugs make it to market, and there is evidence to suggest the ineffectiveness of animal testing in pre-clinical trials. Detached from my own experience, I would consider this information and maintain my anti-animal testing opinions. I would consider if it was truly necessary; when other pre-clinical tests and human alternatives are available in drug development, are we making a justifiable sacrifice? Knowing myself and my weaknesses when confronted with the suffering of vulnerable creatures, I would likely conclude, no.
The use of animal testing for the CCHF virus vaccination was confirmed to me from the first day of my involvement, when I read the participant information form. A casual line in the middle of this lengthy document states: “Data from pre-clinical animal studies show that MVA-CCHF is effective at inducing an immune response.”
I had no symptoms or side effects from the vaccination. According to the nurses on the study, the same was true for all other participants in my group of the first phase. But whoâor whatâdid suffer side effects, or worse? Not once in the year-long trial process did I consider this, until now. The only vague memory I have of a reaction to the animal testing information, when I read that line for the first time, was reassurance.
As I type in level 3 of the Hartley Library, I wonder if I can allow myself to feel guilt.
It is one thing to take a stance against animal testing, and quite another to wait for an experimental vaccine to be administered to you, with little knowledge of the potential side effectsâonly the fact that other living creatures have already received this and it has been deemed safe enough to give to you, a member of a species whose lives are undeniably valued above all others. I lost count of the number of medical personnel who surrounded me on each injection of the vaccine. The research facility must now have enough of my blood to fill a small swimming pool. When the curtains are drawn around you and you spend the next four hours under the watchful eyes of multiple nurses, your vitals checked with unsettling regularity, it is difficult to think of anything besides your safety. Is this response selfish? Here, too, I would argue no.
Now my involvement in the trial is over, I can look back on my experience and question whether I would have taken part without the knowledge that the vaccine had passed animal trials. I have considered the scenario where they hadn’t been performed, and my phase of human trials was therefore the first test on a living organism. As a student of medical sciences, I should be able to look critically at other informationâsuch as the previous success and safety of MVA-based vaccinationsâto make a decision. But no detached, logical assessment would be enough to stamp out the instinctive fear that comes from being injected with an unapproved drug. Without that line in the information sheet, it is likely that I would not have taken the risk.
I have no diagnoses that affected my participation. I consider myself confident with my health. I had no issues with the process of the trialâquite the opposite, since I find blood tests enjoyable. It was academically interesting to me; I got to experience an ECG test in the same month in which I completed an ECG lab project. The reimbursement was an indisputable temptation for a student with concert tickets to pay for. If I, the perfect fit for a clinical trial volunteer, would be put off by the lack of animal testing, then so would many others. How much longer would it take to develop the CCHF vaccine with this drop in volunteers and likely necessity for longer, more tightly controlled human trials? Would we see a spread in the meantime that would lead, as headlines claimed, to the next pandemic? These are extreme hypotheticals, but they are conceived through consideration of my own double standards.
A Tumultuous Attempt at Conclusion
Harvard Medical School belives animal testing to be “a privilege,not a right,” a statement with which I now agree. I have been afforded the privilege of safety and consolation, protected from unrealised side effects and health paranoia behind those animals who, like me, received an experimental drug.
I will keep up to date with progress on the treatment of the CCHF virus. Drug trials are a lengthy process, and by the time the vaccination is approved, I might be a qualified vet. I would take every moment of the care of an animal to be a blessing, but so too would I take the successful treatment of a deadly disease as one. I am left with a new appreciation of the necessity of animal testing after the first-hand realisation of how eradication may not be achieved without it.
Whilst I wrap up this post, I realise I have exceeded the word limit substantially. If I were to remove large chunks of text as required, I would lose important details of the thought process that has spanned many hours since the embryo testing debate to my final trial session last week, and that will stick with me far beyond the submission date. I am politely requesting permission from the examiner of this work to allow me this infringement.
I can conclude that my opinion on animal testing has been rendered more complex, and would like to state another realisation that I hope will be considered for the future of this module: when communicating a reflective process on the subject of medical ethics, five hundred words will never be enough.
Photo: (left to right) my pets Lola, Ginger, and Tommy, the latter of whom I have loved and looked after for seventeen years, and whose appearance on my phone lockscreen made me tear up whilst writing this post.
Following discussion on organ transplants, my reading led me to the debate of head transplantation, which, to those with terminal disease but a healthy head and brain [1], has the potential to extend life. It would be a last-resort treatment for patients whose body is affected but whose mind and head are healthy, hence treating conditions such as quadriplegia, progressive diseases, and inoperable cancers that have not extended to the brain [2]. In 2019, Valery Spiridonovâa man with Werdnig-Hoffmann disease, a muscle-wasting conditionâpulled out of what would have been the first attempted human head transplant [3].
The surgery would require an immunologically matched brain-dead donor with a healthy body, onto which the head of the patient can be transplanted. The procedure has been performed on animals without long-term success [4], and in 2017, it was completed on a human cadaver [5]. Gkasdaris et al. discussed human head transplantation and highlighted the surgical issues involved as donor body selection, head and body interventions on the recipient and donor, ischemia time (managing the blood flow between the head and donor body), spinal fusion and spinal cord reattachment, and post-operative issues [1]. Beyond the surgical hurdles, ethical concerns are raised; notably, the EANS ethico-legal committee concluded that it is ethically unacceptable to attempt a head transplant [6]. Literature considers the great risk involved during and after surgery and the reality of living with the body of another person; for example, a 2017 study by Wolpe considers the extent to which our body, alongside the brain, âmakes us who we areâ [3]. Legality must also be taken into account. Wolpe points out that the surgery involves intentional decapitation, which means that, by definition, the death of a patient would be murder.
The idea of a head transplant is one that we, as the general public, expect to see in science fiction media, and would therefore view as something detached from reality. Frankensteinâs monster is often referenced in this discussion. We would consider the consequences of such a narrativeâwritten to shock and scare usâand conclude that this is not something that should happen in âreal lifeâ. We have been told by the fiction we grow up around to be wary of the scientific unknown and the âmad scientistâ archetype who would attempt something so shocking and seemingly without consideration of ethical questions. It is difficult to suspend these preconceived ideas of what should and should not be done, and dull the instinctive, fearful dismissal of an attempt. Just the phrase âhead transplantâ elicits shock, even as somebody so used to hearing about extreme surgical procedures. Through reading and consideration, I hope to form my own opinion on the subject, beyond general concern and morbid fascination.
I believe that the surgical challenges are the lesser issue when it comes to the feasibility of head transplants. Surgical technique is rapidly advancing and there will come a point in medical knowledge where every challenge associated with the procedure will be surmountable. My reading found this to be an existing approach in the conversation; Spagnolo et al. says, in a paper about the possibility of head transplants, âDespite the uncertainty regarding the technical feasibility of this procedure, for the sake of argument, we will assume that the procedure is possible and feasible to performâ [7]. Even so, the first attempt will come with great risk; if we reached a point where an attempt could be made, should it?
Whilst no comparison can be made to head transplants, this scenario brings to mind the case of Ladan and Laleh Bijani: conjoined twins who both died during a separation attempt on 8 July 2003, at twenty-nine years old. The surgery, which separated their heads, had been denied in 1996 based on high risk [8], but was accepted by another surgical team in 2003 despite major safety concerns. Varying reports exist on which parties involved agreed that the surgery should go ahead, but both twins made clear their desire for the surgery by explaining that their lives conjoined âwere worse than deathâ. Similarities can be drawn between this case and the scenario of a person who would undergo head transplantation to avoid a fate they regarded to be âworse than deathâ. To form an opinion on the head transplant debate, I considered the question of whether Ladan and Lalehâs separation surgery should have been performed, knowing the outcome of it. Can the blame for their deaths be placed on the surgeons, or the twins? Perhaps societal pressureâand the public spectacle of such a novel surgery, with the relations between Singapore and Iran affected as a consequence [9]âcould have contributed to the decision to proceed with the surgery? Hence, was it correct to place such a spotlight on the case, and would the first head transplant be subject to similar public interest that could influence the decisions of the parties involved?
It is my opinion that the correct choice was made in respecting the wishes of the twins. We will once day live in a world where the knowledge will exist to attempt the first human head transplant. There must always be a first, and that first will be performed on a patient who, like Ladan and Laleh, see their current condition as one worth risking death to escape from. Once it can be attempted, then, even with all the concern that remains, I believe that it should. Still, the only conclusion I can confidently draw from this can be summed up by Gkasdris et al.: âThe scientific community should not consider [human head transplantation] as a product of imagination anymoreâ [1].
References:
[1] G. Gkasdaris and T. Birbilis, âFirst Human Head Transplantation: Surgically Challenging, Ethically Controversial and Historically Tempting â an Experimental Endeavor or a Scientific Landmark?,â MĂŚdica, vol. 14, no. 1, pp. 5â11, Mar. 2019, doi: https://doi.org/10.26574/maedica.2019.14.1.5.
[3] Spinalcord. com Team, âWarning Signs of a Serious Spinal Contusion,â Spinalcord.com, Dec. 03, 2020. https://www.spinalcord.com/blog/russian-man-volunteers-to-be-the-first-full-head-transplant (accessed Mar. 06, 2025).
[4] P. R. Wolpe, âAhead of Our Time: Why Head Transplantation Is Ethically Unsupportable,â AJOB Neuroscience, vol. 8, no. 4, pp. 206â210, Oct. 2017, doi: https://doi.org/10.1080/21507740.2017.1392386.
[5] X. Ren et al., âFirst cephalosomatic anastomosis in a human model,â Surgical Neurology International, vol. 8, no. 1, p. 276, 2017, doi: https://doi.org/10.4103/sni.sni_415_17.
[6] J. Brennum, âThe EANS Ethico-legal Committee finds the proposed head transplant project unethical,â Acta Neurochirurgica, vol. 158, no. 12, pp. 2251â2252, Oct. 2016, doi: https://doi.org/10.1007/s00701-016-2986-y.
[7] A. Cartolovni and A. Spagnolo, âEthical considerations regarding head transplantation,â Surgical Neurology International, vol. 6, no. 1, p. 103, 2015, doi: https://doi.org/10.4103/2152-7806.158785.
[8] N. Ahmad and L. Board, âWorldâs first separation of adult Siamese twins in Singapore,â Nlb.gov.sg, 2023. https://www.nlb.gov.sg/main/article-detail?cmsuuid=8909f20d-50e5-43f3-86ee-0fe93f58e0a1 (accessed Oct. 08, 2024).
[9] Wikipedia Contributors, âLadan and Laleh Bijani,â Wikipedia, Jan. 12, 2025.
This is a good blog. It nicely demonstrates a good understanding of organ-on-a-chip technology and clearly explains its purpose and…
This is a good blog, very engaging with a good backgroud to 3D bioprinting. You could improve your blog with…
This is a good, very interesting blog about necrobotics. It explores the idea of necrobiotics which is fairly new approach…
This is a good blog. You introduce the reader to the topic of prosthetics and bionic limbs in a very…
This is a good blog introducing hernia mesh benefits and drawbacks. You create a narrative in this blog, which showcase…